Substance use disorder: Clinical sciences

1,993views

Substance use disorder: Clinical sciences

Watch later

Watch later

Approach to hypertension: Clinical sciences
Chest X-ray interpretation: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
Pericarditis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Right heart failure: Clinical sciences
Temporal arteritis: Clinical sciences
Valvular insufficiency (regurgitation): Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Adrenal insufficiency: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Graves disease: Clinical Sciences
Diabetic ketoacidosis: Clinical sciences
Hashimoto thyroiditis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to hypercoagulable disorders: Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency anemia: Clinical sciences
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Basal cell carcinoma: Clinical sciences
Burns: Clinical sciences
Lyme disease: Clinical sciences
Melanoma: Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Approach to lymphoma: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Opioid use disorder: Clinical sciences
Substance use disorder: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to a fever: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Infectious mononucleosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Myasthenia gravis: Clinical sciences
Osteoarthritis: Clinical sciences
Septic arthritis: Clinical sciences
Spinal fractures: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Spinal infection and abscess: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to blunt traumatic cervical spine injuries: Clinical sciences
Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Delirium: Clinical sciences
Brain death: Clinical sciences
Diabetes insipidus: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Approach to lower limb edema: Clinical sciences
Approach to vasculitis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to vaginal discharge: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Acute respiratory distress syndrome: Clinical sciences
Asthma in pregnancy: Clinical sciences
Airway obstruction: Clinical sciences
Atelectasis: Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Empyema: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Pleural effusion: Clinical sciences
Pulmonary embolism: Clinical sciences
Pneumothorax: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Approach to acute kidney injury: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Chronic kidney disease: Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Asthma: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Empathetic listening for clinicians
Shared decision-making
Implicit bias
The do's and don'ts of patient care
Cardiovascular disease screening: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Randomized control trial
Clinical trials
Study designs
Bias in performing clinical studies
Problem-based learning
Sample size
Information bias
Selection bias
Case-control study
Cohort study
Hypothesis testing: One-tailed and two-tailed tests
Correlation
Paired t-test
Types of data
Bias in interpreting results of clinical studies
Two-sample t-test
The role of the kidney in acid-base balance
Anatomy of the glossopharyngeal nerve (CN IX)
Anticoagulants: Warfarin
Class I antiarrhythmics: Sodium channel blockers
Hepatitis A and Hepatitis E virus
Class IV antiarrhythmics: Calcium channel blockers and others
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the vagus nerve (CN X)
Definitions of acids and bases
Anatomy clinical correlates: Trigeminal nerve (CN V)
Kidney stones: Pathology review
Meningitis
Cellulitis and erysipelas: Clinical sciences
Sepsis: Clinical sciences
Bacterial vaginosis: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Substance use disorder is a medical condition characterized by the inability to control the consumption of a substance despite adverse health and social consequences. The cause of substance use disorder is multifactorial and includes psychological, biological, social, and environmental factors. Based on criteria defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, or DSM-5, you can categorize a substance use disorder as mild, moderate, or severe.

Okay, if a patient presents with a chief concern suggesting a substance use disorder, first perform an ABCDE assessment to determine if the patient is unstable or stable. If your patient is unstable, stabilize the airway, breathing, and circulation, which might require endotracheal intubation with mechanical ventilation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, pulse oximetry, and cardiac telemetry.

Here’s a clinical pearl to keep in mind! Patients with substance use disorder might present with a few potentially unstable conditions. For example, cocaine toxicity can cause cardiac ischemia and seizures, whereas heroin or other opioid toxicity can result in severe drowsiness, respiratory depression, and coma. Benzodiazepine toxicity can also cause CNS depression, whereas benzodiazepine or alcohol withdrawal can cause potentially fatal seizures!

Now that we’ve addressed unstable patients, let’s return to the ABCDE assessment and take a look at stable patients. If the patient is stable, first obtain a focused history and physical exam. Next, assess for substance use with a screening test, such as the Drug Abuse Screening Test, or DAST-10. DAST-10 contains ten “yes” and “no” questions about substance use over the past 12 months and includes illicit drugs, prescription medication and over-the-counter medication. However, keep in mind that this screening test excludes alcohol use.

Now, here’s a high-yield fact! If you suspect your patient is using more than one substance, you might want to use the ASSIST questionnaire, which stands for Alcohol, Smoking, and Substance Involvement Screening Test. This is an 8-question test that identifies misused substances, such as tobacco, alcohol, cannabis, cocaine, stimulants, inhalants, sedatives, hallucinogens, and opioids.

Next, your patient or their close contact may report concerns about their substance use, but keep in mind that some patients may conceal or minimize concerns related to substance use despite associated relationship struggles, such as strained friendships or difficulties with co-workers.

Sometimes, there might be a history of a mood or personality disorder, such as depression or borderline personality disorder, or a childhood trauma, such as parental abandonment. Family history may reveal alcohol or other substance use disorders. Physical examination may reveal abnormal blood pressure, needle puncture marks on the skin, and damaged nasal septum.

Additionally, you may observe abnormal pupils, which could be either dilated or constricted depending on which substance is involved. But, in some cases, your patient’s examination might be completely normal. Finally, if the DAST-10 score is 3 or higher, you should suspect a substance use disorder!

Here’s a clinical pearl! Different substances cause different signs and symptoms. For example, acute toxicity from stimulants like amphetamine and cocaine cause hypertension, tachycardia, and dilated pupils. On the other hand, CNS depressants, such as barbiturates and benzodiazepines, cause somnolence, slowed respiratory rate, hypotension, and pinpoint pupils. Next, with cannabis use, look for conjunctival injection; while those using phencyclidine might present with nystagmus.

Okay, once you suspect a substance use disorder, assess the DSM-5 criteria for substance use disorder. The DSM-5 lists eleven criteria that fall into four general categories including impaired control, physical dependence, social problems, and risky use.

First, let’s discuss factors suggesting impaired control, like if your patient is consuming more substances than intended or for a longer duration than intended. Next, they might be spending more time obtaining, consuming, or recovering from substances; or they continue to use substances despite insight into the problem, like after legal consequences.

Next up is physical dependence, like if they report cravings for substances; have unsuccessful attempts to decrease or stop using them; or even develop withdrawal symptoms, such as tremor or restlessness. Additionally, over time, your patient could develop tolerance to a specific substance, which means they have to take more of it to reach the desired effect.

Sources

  1. "Treatment of patients with substance use disorders, second edition" Am J Psychiatry (2007)
  2. "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)" Arlington, VA (2013)
  3. "Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation" JAMA Intern Med (2020)
  4. "DSM-5 criteria for substance use disorders: recommendations and rationale" Am J Psychiatry (2013)
  5. "Harrison's Principles of Internal Medicine, 21e" McGraw Hill (2022)
  6. "Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health" SAMHSA (2021)